IAP antagonists Birinapant and AT-406 efficiently synergise with either TRAIL, BRAF, or BCL-2 inhibitors to sensitise BRAFV600E colorectal tumour cells to apoptosis.
about
Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs)Resistance to anticancer immunity in cancer patients: potential strategies to reverse resistance.Should We Keep Walking along the Trail for Pancreatic Cancer Treatment? Revisiting TNF-Related Apoptosis-Inducing Ligand for Anticancer Therapy.Promising Antineoplastic Actions of Melatonin
P2860
IAP antagonists Birinapant and AT-406 efficiently synergise with either TRAIL, BRAF, or BCL-2 inhibitors to sensitise BRAFV600E colorectal tumour cells to apoptosis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
IAP antagonists Birinapant and ...... tal tumour cells to apoptosis.
@ast
IAP antagonists Birinapant and ...... tal tumour cells to apoptosis.
@en
type
label
IAP antagonists Birinapant and ...... tal tumour cells to apoptosis.
@ast
IAP antagonists Birinapant and ...... tal tumour cells to apoptosis.
@en
prefLabel
IAP antagonists Birinapant and ...... tal tumour cells to apoptosis.
@ast
IAP antagonists Birinapant and ...... tal tumour cells to apoptosis.
@en
P2093
P2860
P1433
P1476
IAP antagonists Birinapant and ...... tal tumour cells to apoptosis.
@en
P2093
Alexander Pintzas
Alexandra Voulgari
Apostolos Galaris
Margarita Prassa
Philippos Perimenis
P2860
P2888
P356
10.1186/S12885-016-2606-5
P407
P577
2016-08-12T00:00:00Z
P6179
1046598309